| |
| |
|
| Insider
Information: |
Karnani Vikram |
| Relationship: |
EVP & President, Inter... |
| City: |
Dublin |
| State: |
L2 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
104,165 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,947,870 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
104,165 |
|
|
| Total
Value |
$2,947,870 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Horizon Pharma, Inc. |
HZNP |
EVP & President, Inter... |
2021-02-22 |
104,165 |
2017-03-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
37 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HZNP |
Horizon Pharma, Inc. |
SVP, Rheumatology Bus. Unit |
• – – |
2017-03-23 |
4 |
D |
$14.56 |
$43,025 |
D/D |
(2,955) |
27,059 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
SVP, Rheumatology Bus. Unit |
• – – |
2017-03-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,500 |
30,014 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
SVP, Rheumatology Bus. Unit |
• – – |
2017-07-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,675 |
34,162 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
SVP, Rheumatology Bus. Unit |
• – – |
2017-07-31 |
4 |
D |
$11.98 |
$31,891 |
D/D |
(2,662) |
31,500 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Chief Commercial Officer |
• – – |
2018-03-23 |
4 |
D |
$13.86 |
$58,337 |
D/D |
(4,209) |
36,791 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Chief Commercial Officer |
• – – |
2018-03-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,500 |
41,000 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Chief Commercial Officer |
• – – |
2018-07-31 |
4 |
D |
$17.63 |
$29,319 |
D/D |
(1,663) |
43,174 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Chief Commercial Officer |
• – – |
2018-07-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,675 |
44,837 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Chief Commercial Officer |
• – – |
2019-01-05 |
4 |
D |
$20.39 |
$162,345 |
D/D |
(7,962) |
52,471 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Chief Commercial Officer |
• – – |
2019-01-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,259 |
60,433 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Chief Commercial Officer |
• – – |
2019-02-20 |
4 |
D |
$21.54 |
$185,718 |
D/D |
(8,622) |
62,863 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Chief Commercial Officer |
• – – |
2019-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
19,014 |
71,485 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Chief Commercial Officer |
• – – |
2019-03-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,500 |
72,363 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Chief Commercial Officer |
• – – |
2019-03-23 |
4 |
D |
$26.84 |
$112,970 |
D/D |
(4,209) |
68,154 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Chief Commercial Officer |
• – – |
2019-07-01 |
4 |
AS |
$25.02 |
$327,980 |
D/D |
(13,111) |
57,412 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Chief Commercial Officer |
• – – |
2020-01-05 |
4 |
D |
$36.10 |
$874,523 |
D/D |
(24,225) |
87,443 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Chief Commercial Officer |
• – – |
2020-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
19,014 |
111,668 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Chief Commercial Officer |
• – – |
2020-01-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
35,242 |
92,654 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Chief Commercial Officer |
• – – |
2020-01-06 |
4 |
AS |
$35.62 |
$331,159 |
D/D |
(9,297) |
78,146 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Chief Commercial Officer |
• – – |
2020-01-21 |
4/A |
D |
$38.25 |
$83,117 |
D/D |
(2,173) |
80,877 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Chief Commercial Officer |
• – – |
2020-01-21 |
4/A |
A |
$0.00 |
$0 |
D/D |
4,904 |
83,050 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Chief Commercial Officer |
• – – |
2020-02-19 |
4 |
D |
$36.06 |
$239,763 |
D/D |
(6,649) |
89,235 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Chief Commercial Officer |
• – – |
2020-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
15,007 |
95,884 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Chief Commercial Officer |
• – – |
2020-04-28 |
4 |
AS |
$35.01 |
$1,052,506 |
D/D |
(30,063) |
59,172 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Chief Commercial Officer |
• – – |
2020-04-29 |
4 |
AS |
$35.00 |
$548,905 |
D/D |
(15,683) |
43,489 |
0 |
- |
|
37 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
